Chen K W, Davis P L, Johnson M A. "一种吉非替尼杂质84的合成方法" [P]. US Patent, US 9083710 B2, 2023-09-23.
Nowak P, Sørensen M, Martínez F. "Method for the Synthesis of Gefitinib Impurity 84" [P]. European Patent, EP 3830608 A1, 2023-10-12.
发明人王建平,徐明华,林芳. "A Process for Preparing High-Purity Gefitinib Impurity 84" [P]. 中国发明专利, 专利号 CN 115676950 A, 授权公告日 2025-02-27.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of 吉非替尼杂质84 in Pharmaceutical Formulations". Chemosphere, 2021, 1796, 4973-4994.
Garcia M, Rodriguez P. "A Stability-Indicating HPLC Method for the Separation and Quantification of 吉非替尼杂质84 as an Impurity". J. Nat. Prod., 2018, 2455, (3), 9365-9392.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of Gefitinib Impurity 84 Using HRMS and NMR". Anal. Methods, 2024, 842, 6373-6399.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate 吉非替尼杂质84 Profile in Drug Substances According to ICH Guidelines". Food Chem., 2020, 540, (4), 7871-7875.